Skip to content
Abierto
Menu

Combined synopsis and solicitation, total small business set-aside

Virtual Screening

75N92024Q1061

National Institutes of Health, National Institutes of Health Nhlbi. Research and Development in Biotechnology (except Nanobiotechnology).

View on SAM.govMarkdown

Awarded

Targetmol Chemicals Inc.

$35,000.00 obligated so far on USAspending

Description

As published on SAM.gov.

Virtual Screening for compounds increasing GALNT3 mutation stability

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Targetmol Chemicals Inc.
UEI
V8JKN4B7N4T2
CAGE
9M8R3
Vendor location
Wellesley Hills, MA
Contract
75N92024P00310, purchase order
Obligated
$35,000.00
Actions
1 between August 30, 2024 and August 30, 2024
Competition
Competed Under SAP, 1 offer received
Set-aside reported
Small Business Set Aside - Total
Described as
Virtual Screening for Compounds Increasing Galnt3 Mutation Stability
Match
solicitation number 75N92024Q1061 equals the FPDS solicitation identifier; same awarding office 75N920 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 22, 2024

    Combined synopsis and solicitation

    Due August 27, 2024 at 12:00 PM EDT. SAM.gov, notice 9fe05d48366241deb0ce537b4bd901d6

Points of contact

Also open from this buyer